Estithmar Holding's Elegancia Healthcare partners with Korea's EHL Bio for stem cell therapy at Lusail's KMC.

Estithmar Holding's subsidiary, Elegancia Healthcare, has partnered with Korea's EHL Bio R&D Institute to provide stem cell therapy at the upcoming Korean Medical Center (KMC) in Lusail. Through this agreement, KMC will be the exclusive provider of EHL Bio's advanced stem cell technologies in the region, reinforcing Estithmar Holding's commitment to pioneering healthcare advancements and investing in healthcare innovations.

Articles

MENAFN

I Love Qatar

Gulf Times

The Peninsula Qatar

Doha News

Qatar Tribune

-- show less --

Further Reading

Related Stories